J. J. FINKELSTEIN

Insider Reports History

Signature
/s/ Andrew Nick as Attorney-in-Fact for J.J. Finkelstein pursuant to Power of Attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by J. J. FINKELSTEIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Common Stock 1,712,991 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Stock Option (Right to Buy) 600,000 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Convertible Promissory Note (right to buy) 20,880 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Common Stock Warrant (right to buy) 0 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Series A Common Stock Warrant (right to buy) 0 17 May 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Series B Common Stock Warrant (right to buy) 0 17 May 2022 Direct

Insider Reports Filed by J. J. FINKELSTEIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGRX REGENERX BIOPHARMACEUTICALS INC 17 May 2022 1 $0 4 President and CEO, Director 19 May 2022, 17:03
RGRX REGENERX BIOPHARMACEUTICALS INC 02 Aug 2021 1 $0 4 President and CEO, Director 04 Aug 2021, 16:03
RGRX REGENERX BIOPHARMACEUTICALS INC 30 Jun 2021 3 +$15,000 4 President and CEO, Director 06 Jul 2021, 16:35